Navigation Links
Research and Markets Announces the Release of 'Cellulose Ethers Market By Derivative & Application - Global Trends & Forecasts to 2017'
Date:4/2/2013

DUBLIN, April 2, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/55lr6x/cellulose_ethers) has announced the addition of the "Cellulose Ethers Market By Derivative [Methyl, Ethyl & Carboxymethyl Cellulose] & Application [Pharmaceuticals, Personal Care, Construction, Food & Beverages, Surface Coatings & Paints] - Global Trends & Forecasts to 2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The report covers the major cellulose ether market which includes carboxymethyl cellulose, methyl cellulose & derivatives and ethyl cellulose & derivatives. It also studies sub segments including methyl cellulose, hydroxy propyl methyl cellulose, hydroxy ethyl methyl cellulose, hydroxy ethyl cellulose, and ethyl cellulose. The report analyses the market for cellulose ether with respect to market drivers, opportunities, and winning imperatives related to the industry. The market study also includes microcrystalline cellulose powder and its applications in pharmaceuticals, food, and other industries.

The total market for cellulose ether has been analyzed based on the porter's five forces model. This gives an idea about the current on goings in the industry at a commercial level. The report also provides market share for cellulose ether manufacturers. It represents the top players contributing to the cellulose ether industry. The market is also analyzed based on the patents filled by different industrial participants over a period of time. This elaborates about the latest products and technologies within the cellulose ether market on which the manufacturers have been focusing over the past few years.

Cellulose ether and its derivatives have been used in diverse application including food & beverages, drugs, cosmetics, personal care, construction, surface coatings, etc. Carboxymethyl cellulose is the major market with respect to volume demand. It has a wide band of applications within different industries including food ingredients, pharmaceuticals, cosmetics, paper products, adhesives, lithography, ceramics, detergents, and textiles. Such diverse applications along with its low pricing have made carboxymethyl cellulose as one of the major market share holder within all the cellulose ether product categories.

The market is analyzed based on different types of cellulose ethers and their derivatives. These include carboxymethyl cellulose, methyl cellulose, hydroxy propyl methyl cellulose, hydroxy ethyl methyl cellulose, hydroxy ethyl cellulose, and ethyl cellulose. The market data for these product types is given with respect to volume (thousand tons) and value ($million). The data is based on the demand for all the cellulose ether categories.

Key Topics Covered:


1 Introduction

2 Executive Summary

3 Market Overview

4 Global Cellulose Ether Market, By Product Type

5 Global Cellulose Ether Market, By Application

6 Cellulose Ether Market, By Geography

7 Microcrystalline Cellulose

8 Competitive Landscape

9 Company Profiles

 

Companies Mentioned


- Akzonobel Performance Additives
- Ashland Speciality Chemicals
- China Ruitai International Holdings Co. Ltd
- Cp Kelco
- Daicel Fine Chem Ltd
- Dai-Ichi Kogyo Seiyaku Co. Ltd
- The Dow Chemical Company
- Fenchem Biotek Ltd
- Hercules Tianpu Chemical Co. Ltd
- Jrs (J. Rettenmaier & Söhne Gmbh + Co. Kg)
- Reliance Cellulose Products Ltd
- Samsung Fine Chemicals
- Se Tylose Gmbh & Co. Kg
- Shandong Head Co. Ltd
- Shin Etsu Chemical Co. Ltd
- Sichem
- Zhejiang Kehong Chemical Co. Ltd

For more information visit http://www.researchandmarkets.com/research/55lr6x/cellulose_ethers

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Chemicals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
2. Two Of The Nations Top Specialists In Lupus, Drs. Swamy Venuturupalli & Daniel Wallace, Join In Expanding Research On Auto-Immune Diseases
3. ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan
4. Doing Business in China: Research on Chinese Good Manufacturing Practice Regulations for Medical Devices
5. Quantum Materials Corporation Supplies Tetrapod Quantum Dots to U.S. Government Researchers
6. MedNet Solutions To Participate In Multiple Clinical Research Conferences In April 2013
7. Family Tree DNAs Genomics Research Center Facilitates Discovery of Extremely Ancient Root to the Human Y Chromosome Phylogenetic Tree
8. RFID-over-Wi-Fi RTLS Temperature Sensing Solution Protects Clinical Research Specimens at Fred Hutchinson Cancer Research Center
9. Texas Research Institutions Conducted Over 8,200 Clinical Trials of Medicines Since 1999
10. Research and Markets Announces The Release of Neuromodulation Market - Forecasts to 2017
11. New Research Indicating Serious Potential Risks To Cancer Patients From Oncology Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery , one of this ... A-Round, according to CEO Leen Kawas , PhD. ... ... ... Kawas said the round was intended ...
(Date:2/11/2016)... CARLSBAD, Calif. , Feb.11, 2016  Ionis Pharmaceuticals, Inc. ... a live webcast on Thursday, February 25 at 11:30 a.m. ... on pipeline and business progress. www.ionispharma.com . ... at the same address. --> www.ionispharma.com . A ... the same address. --> Interested parties may listen ...
(Date:2/11/2016)... -- Indiso ltd , a medical technology company ... respiratory diseases announced today positive results in its clinical ... patients show improvements in respiratory functions and other clinical ... Upper and lower respiratory tract diseases and allergy ... reached epidemic level. Increasing number of studies however show ...
Breaking Medicine Technology:
(Date:2/11/2016)... DC (PRWEB) , ... February 11, 2016 , ... ... an upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for ... not-for-profit Catholic health care system that’s partnering with Intel on value-based health benefits ...
(Date:2/11/2016)... ... February 11, 2016 , ... veEDIS Clinical Systems, ... with highly adaptable algorithms, has been updated to help Emergency Department physicians and ... consistent with Zikas and a travel history to affected regions, or potential exposure ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... call for nominations seeking candidates for the Board of Commissioners. Individuals interested in ... skills and experience with diversity of clinical practice settings and across allied health ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you back from ... poses a question as a challenge for his readers to examine the full ... Being" (published by Partridge Singapore), Clarke explores the subject with more depth, revealing ...
(Date:2/11/2016)... ... 11, 2016 , ... PharmMD CEO Robert Yeager ... focus on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will ... in data breaches for the Part D Star Rating improvement and Medication Therapy ...
Breaking Medicine News(10 mins):